Normocalcemic primary hyperparathyroidism

Jad G. Sfeir, Matthew M Drake

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Over the past two decades, normocalcemic primary hyperparathyroidism (NPHPT) has emerged as a new subset of primary hyperparathyroidism which, after exclusion of secondary hyperparathyroidism, is characterized by consistent normocalcemia with elevated parathyroid hormone levels. Population-based epidemiologic data lack reproducibility and generalizability. NPHPT has primarily been diagnosed in subjects referred for evaluation of symptoms related to this metabolic disease. However, an asymptomatic phase of the disease does appear to occur in the general population, suggesting that primary hyperparathyroidism is a spectrum that encompasses both normocalcemia and hypercalcemia that occurs in parallel with, but is not necessarily linked to, silent and symptomatic disease. In the current absence of good evidence, management recommendations for asymptomatic PHPT cannot be applied to patients with NPHPT.

Original languageEnglish (US)
Title of host publicationHyperparathyroidism: A Clinical Casebook
PublisherSpringer International Publishing
Pages157-167
Number of pages11
ISBN (Print)9783319258805, 9783319258782
DOIs
StatePublished - Jan 1 2016

Fingerprint

Primary Hyperparathyroidism
Asymptomatic Diseases
Secondary Hyperparathyroidism
Symptom Assessment
Metabolic Diseases
Hypercalcemia
Parathyroid Hormone
Population

Keywords

  • Bone mineral density
  • Hypercalcemia
  • Nephrolithiasis
  • Normocalcemia
  • Normocalcemic primary hyperparathyroidism
  • Osteoporosis
  • Parathyroidectomy
  • Primary hyperparathyroidism
  • Secondary hyperparathyroidism
  • Vitamin d

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sfeir, J. G., & Drake, M. M. (2016). Normocalcemic primary hyperparathyroidism. In Hyperparathyroidism: A Clinical Casebook (pp. 157-167). Springer International Publishing. https://doi.org/10.1007/978-3-319-25880-5_18

Normocalcemic primary hyperparathyroidism. / Sfeir, Jad G.; Drake, Matthew M.

Hyperparathyroidism: A Clinical Casebook. Springer International Publishing, 2016. p. 157-167.

Research output: Chapter in Book/Report/Conference proceedingChapter

Sfeir, JG & Drake, MM 2016, Normocalcemic primary hyperparathyroidism. in Hyperparathyroidism: A Clinical Casebook. Springer International Publishing, pp. 157-167. https://doi.org/10.1007/978-3-319-25880-5_18
Sfeir JG, Drake MM. Normocalcemic primary hyperparathyroidism. In Hyperparathyroidism: A Clinical Casebook. Springer International Publishing. 2016. p. 157-167 https://doi.org/10.1007/978-3-319-25880-5_18
Sfeir, Jad G. ; Drake, Matthew M. / Normocalcemic primary hyperparathyroidism. Hyperparathyroidism: A Clinical Casebook. Springer International Publishing, 2016. pp. 157-167
@inbook{b12eb5cf336043f9b2d9224ad7c40de9,
title = "Normocalcemic primary hyperparathyroidism",
abstract = "Over the past two decades, normocalcemic primary hyperparathyroidism (NPHPT) has emerged as a new subset of primary hyperparathyroidism which, after exclusion of secondary hyperparathyroidism, is characterized by consistent normocalcemia with elevated parathyroid hormone levels. Population-based epidemiologic data lack reproducibility and generalizability. NPHPT has primarily been diagnosed in subjects referred for evaluation of symptoms related to this metabolic disease. However, an asymptomatic phase of the disease does appear to occur in the general population, suggesting that primary hyperparathyroidism is a spectrum that encompasses both normocalcemia and hypercalcemia that occurs in parallel with, but is not necessarily linked to, silent and symptomatic disease. In the current absence of good evidence, management recommendations for asymptomatic PHPT cannot be applied to patients with NPHPT.",
keywords = "Bone mineral density, Hypercalcemia, Nephrolithiasis, Normocalcemia, Normocalcemic primary hyperparathyroidism, Osteoporosis, Parathyroidectomy, Primary hyperparathyroidism, Secondary hyperparathyroidism, Vitamin d",
author = "Sfeir, {Jad G.} and Drake, {Matthew M}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-25880-5_18",
language = "English (US)",
isbn = "9783319258805",
pages = "157--167",
booktitle = "Hyperparathyroidism: A Clinical Casebook",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Normocalcemic primary hyperparathyroidism

AU - Sfeir, Jad G.

AU - Drake, Matthew M

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Over the past two decades, normocalcemic primary hyperparathyroidism (NPHPT) has emerged as a new subset of primary hyperparathyroidism which, after exclusion of secondary hyperparathyroidism, is characterized by consistent normocalcemia with elevated parathyroid hormone levels. Population-based epidemiologic data lack reproducibility and generalizability. NPHPT has primarily been diagnosed in subjects referred for evaluation of symptoms related to this metabolic disease. However, an asymptomatic phase of the disease does appear to occur in the general population, suggesting that primary hyperparathyroidism is a spectrum that encompasses both normocalcemia and hypercalcemia that occurs in parallel with, but is not necessarily linked to, silent and symptomatic disease. In the current absence of good evidence, management recommendations for asymptomatic PHPT cannot be applied to patients with NPHPT.

AB - Over the past two decades, normocalcemic primary hyperparathyroidism (NPHPT) has emerged as a new subset of primary hyperparathyroidism which, after exclusion of secondary hyperparathyroidism, is characterized by consistent normocalcemia with elevated parathyroid hormone levels. Population-based epidemiologic data lack reproducibility and generalizability. NPHPT has primarily been diagnosed in subjects referred for evaluation of symptoms related to this metabolic disease. However, an asymptomatic phase of the disease does appear to occur in the general population, suggesting that primary hyperparathyroidism is a spectrum that encompasses both normocalcemia and hypercalcemia that occurs in parallel with, but is not necessarily linked to, silent and symptomatic disease. In the current absence of good evidence, management recommendations for asymptomatic PHPT cannot be applied to patients with NPHPT.

KW - Bone mineral density

KW - Hypercalcemia

KW - Nephrolithiasis

KW - Normocalcemia

KW - Normocalcemic primary hyperparathyroidism

KW - Osteoporosis

KW - Parathyroidectomy

KW - Primary hyperparathyroidism

KW - Secondary hyperparathyroidism

KW - Vitamin d

UR - http://www.scopus.com/inward/record.url?scp=84960382054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960382054&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-25880-5_18

DO - 10.1007/978-3-319-25880-5_18

M3 - Chapter

SN - 9783319258805

SN - 9783319258782

SP - 157

EP - 167

BT - Hyperparathyroidism: A Clinical Casebook

PB - Springer International Publishing

ER -